日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma models

错配修复缺陷驱动恶性进展并改变胶质母细胞瘤模型中的肿瘤免疫微环境

Puigdelloses Vallcorba, Montserrat; Soni, Nishant; Choi, Seung-Won; Rawat, Kavita; Joshi, Tanvi; Friedman, Sam; Buonfiglioli, Alice; Angione, Angelo; Chen, Zhihong; Piñero, Gonzalo; Price, Gabrielle; Dedhia, Mehek; Roche, Raina; Radkevich, Emir; Bowcock, Anne M; Bhatt, Deepti; Edelmann, Winfried; Samstein, Robert M; Richardson, Timothy E; Tsankova, Nadejda M; Tsankov, Alexander M; Bindra, Ranjit S; Rabadan, Raul; Vasquez, Juan C; Hambardzumyan, Dolores

Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas

帕米帕利联合节拍式替莫唑胺治疗复发性异柠檬酸脱氢酶突变型胶质瘤的I/II期及机会窗口研究

Schiff, David; Ye, Xiaobu; Li, Jing; Ellingson, Benjamin M; Wen, Patrick Y; Walbert, Tobias; Campian, Jian; Nabors, Louis B; Ozer, Byram H; Desai, Arati; Omuro, Antonio; Desideri, Serena; Danda, Neeraja; Grossman, Stuart; Bindra, Ranjit S

DNA damage response profile distinguishes poor-acting gliomas with shared methylome signatures

DNA损伤反应谱可区分具有共同甲基化组特征的不良预后胶质瘤

Leelatian, Nalin; Singh, Charu; Bouffard, Richard; Sundaram, Ranjini K; Diggins, Kirsten E; Sullivan, William; Paradkar, Sateja; Omay, Zeynep Erson; Mobley, Bret C; Gueble, Susan E; Vasquez, Juan C; Bindra, Ranjit S

Synthesis and Biological Evaluation of Colibactin Derivatives

大肠杆菌素衍生物的合成及生物学评价

Airan, Yougant; Fedorova, Olga; Heer, Collin; Rees, Matthew G; Ronan, Melissa M; Roth, Jennifer A; Bindra, Ranjit S; Herzon, Seth B

Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes

靶向 CRISPR 基因敲除筛选可识别 DNA 损伤剂与 DNA 修复基因之间已知的和新的化学基因组学相互作用

Heer, Collin D; Elia, James L; Menon, Vijay; Johnson, Spenser S; Arbelaez, Sofia R; Friedman, Sam; Lopez-Giraldez, Francesc; Sundaram, Ranjini K; Herzon, Seth B; Bindra, Ranjit S; Gueble, Susan E

Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer.

系统性地施用一种 RNA 结合和细胞穿透抗体,将治疗性 RNA 靶向应用于多种小鼠癌症模型

Quijano Elias, Martinez-Saucedo Diana, Ianniello Zaira, Pinto-Medici Natasha, Rackear Madison, Chen Haoting, Lola-Pereira Luiz, Liu Yanfeng, Hegan Denise, Shan Xinning, Tseng Robert, Yugawa Deanne, Chowdhury Sumedha, Khang Minsoo, Singh Jay P, Abdullah Rashed, Azhir Perisa, Kashima Soki, Woods Wendy S, Gosstola Nicholas, Turner Bruce C, Squinto Stephen, Ludwig Dale L, Bindra Ranjit S, Robert Marie E, Braun David A, Perez Pinera Pablo, Saltzman W Mark, Escobar-Hoyos Luisa F, Glazer Peter M

Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions

青少年和青年中枢神经系统肿瘤:神经肿瘤学会关于诊断、治疗和未来方向的共识性综述

Lim-Fat, Mary Jane; Bennett, Julie; Ostrom, Quinn; Touat, Mehdi; Franceschi, Enrico; Schulte, Jessica; Bindra, Ranjit S; Fangusaro, Jason; Dhall, Girish; Nicholson, James; Jackson, Sadhana; Davidson, Tom Belle; Calaminus, Gabriele; Robinson, Giles; Whittle, James R; Hau, Peter; Ramaswamy, Vijay; Pajtler, Kristian W; Rudà, Roberta; Foreman, Nicholas K; Hervey-Jumper, Shawn L; Das, Sunit; Dirks, Peter; Bi, Wenya Linda; Huang, Annie; Merchant, Thomas E; Fouladi, Maryam; Aldape, Kenneth; Van den Bent, Martin J; Packer, Roger J; Miller, Julie J; Reardon, David A; Chang, Susan M; Haas-Kogan, Daphne; Tabori, Uri; Hawkins, Cynthia; Monje, Michelle; Wen, Patrick Y; Bouffet, Eric; Yeo, Kee Kiat

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

成人胶质母细胞瘤:神经肿瘤学会 (SNO) 和欧洲神经肿瘤学会 (EANO) 关于当前治疗和未来方向的共识性综述

Wen, Patrick Y; Weller, Michael; Lee, Eudocia Q; Touat, Mehdi; Khasraw, Mustafa; Rahman, Rifaquat; Platten, Michael; Lim, Michael; Winkler, Frank; Horbinski, Craig; Verhaak, Roel G W; Huang, Raymond Y; Ahluwalia, Manmeet S; Albert, Nathalie L; Tonn, Joerg-Christian; Schiff, David; Barnholtz-Sloan, Jill S; Ostrom, Quinn; Aldape, Kenneth D; Batchelor, Tracy T; Bindra, Ranjit S; Chiocca, E Antonio; Cloughesy, Timothy F; DeGroot, John F; French, Pim; Galanis, Evanthia; Galldiks, Norbert; Gilbert, Mark R; Hegi, Monika E; Lassman, Andrew B; Le Rhun, Emilie; Mehta, Minesh P; Mellinghoff, Ingo K; Minniti, Giuseppe; Roth, Patrick; Sanson, Marc; Taphoorn Andreas, Martin J B; Weiss, von Deimling Tobias; Wick, Wolfgang; Zadeh, Gelareh; Reardon, David A; Chang, Susan M; Short, Susan C; van den Bent, Martin J; Preusser, Matthias

The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.

新型 DNA 交联剂 KL-50 对替莫唑胺治疗后新发和复发性错配修复缺陷型胶质母细胞瘤的患者来源模型具有活性

McCord Matthew, Sears Thomas, Wang Wenxia, Chaliparambil Rahul, An Shejuan, Sarkaria Jann, James C David, Ruggeri Bruce, Gueble Susan, Bindra Ranjit, Horbinski Craig

Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial

奥拉帕尼治疗难治性异柠檬酸脱氢酶 1 (IDH1) 和 IDH2 突变型胆管癌:来自美国国家癌症研究所 10129 II 期试验的安全性和抗肿瘤活性

Cecchini, Michael; Pilat, Mary Jo; Uboha, Nataliya; Azad, Nilofer S; Cho, May; Davis, Elizabeth J; Ahnert, Jordi Rodon; Tinoco, Gabriel; Shapiro, Geoffrey I; Khagi, Simon; Powers, Benjamin; Spencer, Kristen; Groisberg, Roman; Drappatz, Jan; Chen, Li; Das, Biswajit; Bao, Xun; Li, Jing; Narayan, Azeet; Vu, Dennis; Patel, Abhijit; Niger, Monica; Doroshow, Deborah; Durecki, Diane; Boerner, Scott A; Bindra, Ranjit; Ivy, Percy; Shyr, Derek; Shyr, Yu; LoRusso, Patricia M